SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Biotech Short Candidates
An SI Board Since December 2000
Posts SubjectMarks Bans
897 95 0
Emcee:  tuck Type:  Unmoderated
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
172It is a SEPR type play. They allow big pharma to extend the patent lives of druMichael Young-1/4/2002
171Thanks, Mike, A ticker, that's more like it. Under some legal pressure, totuck-1/3/2002
170I'd vote for BVF. Very strong revenue and EPS growth, although probably notMichael Young-1/3/2002
169Wilder, I don't have a boss. Anyone with a boss want to give us a pick? Ctuck-1/3/2002
168Here's a short idea. Your boss knows you have an interest in BT investing. keokalani'nui-1/3/2002
167Har! If they talk to Russell Glass, he'd better just say no! This could be tuck-1/3/2002
166Disease Sciences is at it again, especially with last sentence: >>Press Rkeokalani'nui-1/3/2002
165Yes. Two challenges. In my view, the one that matters (and is unlikely to be sekeokalani'nui-1/1/2002
164Rick, Wilder, and All, I don't think IMCL got whacked hard enough, and it&#tuck-12/31/2001
163Yeah, the value, if any, is in the backup(s). That much I knew. Thanks for clascaram(o)uche-12/28/2001
162I tried to dig out the "value" of the ETa compounds and IP contributedkeokalani'nui-12/28/2001
161I was joking. The "red wine study" showed an effect reducing endothelscaram(o)uche-12/27/2001
160[AND] 55 VaxGen Inc 1,678,815 100,761 17Doc Bones-12/26/2001
159The stocks with most days-to-cover the short position, as of mid-December, that Doc Bones-12/26/2001
158Rick, Over on the Valuation thread you floated the concept of shorting TXBI. Ituck-12/25/2001
157Tuck, I believe that 1943 Securities law has the margin requirements for "michael_f_murphy-12/24/2001
156Hi, Michael, I searched SEC and couldn't find anything about that. They hatuck-12/24/2001
155re shorting NWBT: don't think one can buy on margin or short for 30 days aftmichael_f_murphy-12/24/2001
154Sooo . . . AMGN sounding like the best possibility at the moment. Also situck-12/24/2001
153<GENZ> <i>it's reliant for the bulk of its growth on a single dBiomaven-12/23/2001
152The Barron's article had some comments on GENZ: "Genzyme, at 60, doesnIRWIN JAMES FRANKEL-12/22/2001
151In going through my lists, it seems the market has done a pretty good job of weetuck-12/22/2001
150Peter and Michael, Thanks for the reminders. I've had LGND in "set antuck-12/22/2001
149I sold LGND at 17 in 1996 and loudly made the "nothing but dilution for forscaram(o)uche-12/22/2001
148tuck, I don't know about the short term, but I feel that both these stocks Biomaven-12/22/2001
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):